GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taienkang Pharmaceutical Co Ltd (SZSE:301263) » Definitions » ROCE %

Guangdong Taienkang Pharmaceutical Co (SZSE:301263) ROCE % : 7.43% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Guangdong Taienkang Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Guangdong Taienkang Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 7.43%.


Guangdong Taienkang Pharmaceutical Co ROCE % Historical Data

The historical data trend for Guangdong Taienkang Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taienkang Pharmaceutical Co ROCE % Chart

Guangdong Taienkang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.99 36.15 20.99 16.02 10.06

Guangdong Taienkang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.22 4.31 11.16 9.58 7.43

Guangdong Taienkang Pharmaceutical Co ROCE % Calculation

Guangdong Taienkang Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=194.026/( ( (2039.588 - 156.325) + (2229.112 - 253.129) )/ 2 )
=194.026/( (1883.263+1975.983)/ 2 )
=194.026/1929.623
=10.06 %

Guangdong Taienkang Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=143.26/( ( (2254.485 - 340.451) + (2285.144 - 340.708) )/ 2 )
=143.26/( ( 1914.034 + 1944.436 )/ 2 )
=143.26/1929.235
=7.43 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Taienkang Pharmaceutical Co  (SZSE:301263) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Guangdong Taienkang Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Guangdong Taienkang Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Taienkang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Wanji South Second Street, Taishan North Road, Building A, Longhu District, Guangdong Province, Shantou, CHN, 515041
Guangdong Taienkang Pharmaceutical Co Ltd is engaged in the research and development, production, sales of pharmaceutical products, medical equipment, sanitary materials, and provision of medical-technical services and technology transfer.
Executives
Li Ting Directors, Directors, and Executives
Zhou Gui Xi Executives
Chen Chun Directors, executives

Guangdong Taienkang Pharmaceutical Co Headlines

No Headlines